TY  - GEN
AU  - Kajiura,Shinya
AU  - Hosokawa,Ayumu
AU  - Yoshita,Hiroki
AU  - Ueda,Yuko
AU  - Ueda,Akira
AU  - Mihara,Hiroshi
AU  - Ando,Takayuki
AU  - Fujinami,Haruka
AU  - Nishikawa,Jun
AU  - Ogawa,Kohei
AU  - Minemura,Masami
AU  - Sugiyama,Toshiro
TI  - Phase I Study of Docetaxel Plus Nedaplatin in Patients With Metastatic or Recurrent Esophageal Squamous Cell Carcinoma After Cisplatin Plus 5-Fluorouracil Treatment
SN  - 1537-453X
PY  - 2016///0606
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Bone Neoplasms
KW  - drug therapy
KW  - Carcinoma, Squamous Cell
KW  - Cisplatin
KW  - administration & dosage
KW  - Disease-Free Survival
KW  - Docetaxel
KW  - Dose-Response Relationship, Drug
KW  - Esophageal Neoplasms
KW  - Esophageal Squamous Cell Carcinoma
KW  - Female
KW  - Fluorouracil
KW  - Humans
KW  - Leukopenia
KW  - chemically induced
KW  - Liver Neoplasms
KW  - Lung Neoplasms
KW  - Lymph Nodes
KW  - pathology
KW  - Male
KW  - Middle Aged
KW  - Nausea
KW  - Neoplasm Metastasis
KW  - Neoplasm Recurrence, Local
KW  - Neutropenia
KW  - Organoplatinum Compounds
KW  - Taxoids
KW  - Treatment Failure
KW  - Vomiting
N1  - Publication Type: Clinical Trial, Phase I; Journal Article
UR  - https://doi.org/10.1097/COC.0000000000000018
ER  -